Dapagliflozin vs Erlotinib

Dapagliflozin vs Erlotinib: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Erlotinib.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Erlotinib — 36 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6; Erlotinib — C22H23N3O4.

Molecular Weight: Dapagliflozin — 408.8730 g/mol; Erlotinib — 393.4380 g/mol.

Type: Dapagliflozin — Small molecule; Erlotinib — Small molecule.